These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 23360312)

  • 1. Laser therapy in metabolic syndrome-related kidney injury.
    Ucero AC; Sabban B; Benito-Martin A; Carrasco S; Joeken S; Ortiz A
    Photochem Photobiol; 2013; 89(4):953-60. PubMed ID: 23360312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetic nephropathy and long-term treatment effects of rosiglitazone and enalapril in obese ZSF1 rats.
    Bilan VP; Salah EM; Bastacky S; Jones HB; Mayers RM; Zinker B; Poucher SM; Tofovic SP
    J Endocrinol; 2011 Sep; 210(3):293-308. PubMed ID: 21680617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early renal injury induced by caffeine consumption in obese, diabetic ZSF1 rats.
    Tofovic SP; Salah EM; Jackson EK; Melhem M
    Ren Fail; 2007; 29(7):891-902. PubMed ID: 17994459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet.
    Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N
    Hypertens Res; 2008 Apr; 31(4):745-55. PubMed ID: 18633187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of acute functional injury following percutaneous renal artery intervention.
    Davies MG; Saad WE; Peden EK; Mohiuddin IT; Naoum JJ; Lumsden AB
    Ann Vasc Surg; 2008 Nov; 22(6):783-9. PubMed ID: 18692990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthy bone marrow cells reduce progression of kidney failure better than CKD bone marrow cells in rats with established chronic kidney disease.
    van Koppen A; Joles JA; Bongartz LG; van den Brandt J; Reichardt HM; Goldschmeding R; Nguyen TQ; Verhaar MC
    Cell Transplant; 2012; 21(10):2299-312. PubMed ID: 23231961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. AT1 blockade during lactation as a model of chronic nephropathy: mechanisms of renal injury.
    Machado FG; Poppi EP; Fanelli C; Malheiros DM; Zatz R; Fujihara CK
    Am J Physiol Renal Physiol; 2008 Jun; 294(6):F1345-53. PubMed ID: 18400868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Hydroxyestradiol attenuates the development of obesity, the metabolic syndrome, and vascular and renal dysfunction in obese ZSF1 rats.
    Tofovic SP; Dubey RK; Jackson EK
    J Pharmacol Exp Ther; 2001 Dec; 299(3):973-7. PubMed ID: 11714885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and obesity-initiated metabolic syndrome: mechanistic links to chronic kidney disease.
    Wahba IM; Mak RH
    Clin J Am Soc Nephrol; 2007 May; 2(3):550-62. PubMed ID: 17699463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
    Toblli JE; Cao G; Giani JF; Muñoz MC; Angerosa M; Dominici FP
    J Hypertens; 2011 Aug; 29(8):1613-23. PubMed ID: 21720265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of chronic kidney disease in Jing adults in China: a village-based study.
    Xue C; Ye XD; Li W; Peng Q; Ding HY; Zhang YH; He DF; Bai X; Huang Y; Song YS; Pang L; Liao YH
    Clin Nephrol; 2013 Jan; 79(1):50-6. PubMed ID: 22948117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal disease in obesity: the need for greater attention.
    Rutkowski P; Klassen A; Sebekova K; Bahner U; Heidland A
    J Ren Nutr; 2006 Jul; 16(3):216-23. PubMed ID: 16825023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renoprotective effects of an angiotensin II receptor blocker in experimental model rats with hypertension and metabolic disorders.
    Watanabe D; Tanabe A; Naruse M; Morikawa S; Ezaki T; Takano K
    Hypertens Res; 2009 Sep; 32(9):807-15. PubMed ID: 19662019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic syndrome and chronic kidney disease.
    Guarnieri G; Zanetti M; Vinci P; Cattin MR; Pirulli A; Barazzoni R
    J Ren Nutr; 2010 Sep; 20(5 Suppl):S19-23. PubMed ID: 20797564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of tumor necrosis factor-alpha reduces renal fibrosis and hypertension in rats with renal failure.
    Therrien FJ; Agharazii M; Lebel M; Larivière R
    Am J Nephrol; 2012; 36(2):151-61. PubMed ID: 22813949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there an obesity-metabolic syndrome related glomerulopathy?
    Ritz E; Koleganova N; Piecha G
    Curr Opin Nephrol Hypertens; 2011 Jan; 20(1):44-9. PubMed ID: 21088574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of low-level laser therapy and eccentric exercises in the treatment of recreational athletes with chronic achilles tendinopathy.
    Stergioulas A; Stergioula M; Aarskog R; Lopes-Martins RA; Bjordal JM
    Am J Sports Med; 2008 May; 36(5):881-7. PubMed ID: 18272794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and risk of development of chronic kidney disease: the Niigata preventive medicine study.
    Watanabe H; Obata H; Watanabe T; Sasaki S; Nagai K; Aizawa Y
    Diabetes Metab Res Rev; 2010 Jan; 26(1):26-32. PubMed ID: 20014332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.